Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rylo Health vs Sumbare Wellness

Rylo Health
Graded #236

Higher grade

vs+2.8000000000000043
Sumbare Wellness
Graded #281

Lower grade

The verdict

Rylo Health takes it — 64.7/100 to 61.9/100.

Rylo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Texas-prescriber telehealth selling compounded semaglutide and tirzepatide alongside a peptide line, naming both its medical group and its dispensing pharmacy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSumbare Wellness +2
64
66
Dose & formulationSumbare Wellness +8
64
72
Clinical oversightRylo Health +19
75
56
Labs & monitoringRylo Health +1
53
52
FulfillmentRylo Health +24
83
59
Contract termsSumbare Wellness +24
37
61
Rylo Health · left barSumbare Wellness · right bar

The numbers

MetricRylo HealthSumbare Wellness
WeighScore64.7/10061.9/100
GradeCC
Scorecard rank#236#281
Semaglutide$149/mo (promotional rate, compounded)$199/mo (all doses, compounded)
Tirzepatide$249/mo (compounded)$199/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Rylo Health

Graded #236 · C

Strengths

  • Names its dispensing pharmacy in full, with address and phone: VialsRX in Houston, Texas
  • Names its medical group, Lone Star Virtual Health PLLC, and gives a provider contact
  • Standard prices published openly alongside the promotional rate, so the real ongoing cost is visible
  • Cancel in one click from the patient portal, with no contracts and no cancellation fees
  • Peptide line priced openly, including NAD+ and sermorelin

Where it loses points

  • Headline $100 and $160 rates are limited to the first 20 patients; standard rates are $149 and $249
  • No LegitScript certification is claimed or displayed
  • Several peptide products are advertised as coming soon rather than available
  • No published refund policy beyond the no-cancellation-fee statement
Sumbare Wellness

Graded #281 · C

Strengths

  • One flat $199/month price covering medication, provider review and shipping, with no consultation fee and no dose-change surcharge
  • Charges nothing if a provider does not approve you
  • Offers a deliberate low-dose microdosing protocol aimed at body composition, which most competitors do not break out
  • Publishes a named legal entity, a US mailing address and a working phone number
  • Pre-screening quiz is short and asks your goal before any medical question

Where it loses points

  • Cancellation terms contradict three ways: the homepage says cancel anytime, the Terms say 48 hours notice, the FAQ says 30 days
  • Availability is unclear: the homepage counter reads 3 states while the treatment pages say telehealth nationwide, and no state list is published
  • Its chart cites placebo-controlled trials of compounded semaglutide and tirzepatide, which do not exist; those trials studied the branded drugs
  • No compounding pharmacy is named, and neither 503A nor 503B appears anywhere on the site
  • Any returned prescription is charged a $35 disposal fee, and prescription orders cannot be cancelled at all after 24 hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard